Page last updated: 2024-08-22

rhenium and Bone Cancer

rhenium has been researched along with Bone Cancer in 102 studies

Research

Studies (102)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (3.92)	18.7374
1990's	37 (36.27)	18.2507
2000's	49 (48.04)	29.6817
2010's	10 (9.80)	24.3611
2020's	2 (1.96)	2.80

Authors

Authors	Studies
Flux, G; Liepe, K; Murray, I	1
Bahrami Samani, A; Pourhabib, Z; Ranjbar, H	1
Asabella, AN; Nicoletti, A; Rubini, D; Rubini, G	1
Badiavas, K; Doumas, A; Farmakis, G; Frangos, S; Iakovou, I; Mpalaris, V	1
Guerra Liberal, FD; Tavares, AA; Tavares, JM	1
Belchior, A; Correia, JD; Fernandes, C; Gano, L; Marques, F; Monteiro, S; Santos, I	1
Arteaga de Murphy, C; Ferro-Flores, G	1
de Klerk, JM; Hoekstra, A; Lam, MG; van Rijk, PP; Zonnenberg, BA	1
Bosma, TB; Lam, MG; van Rijk, PP; Zonnenberg, BA	1
Bergmann, R; Geidel, HH; Haase, M; Kotzerke, J; Liepe, K; Runge, R	1
Blower, PJ; Finucane, C; Mather, SJ; Torres Martin de Rosales, R	1
Blower, PJ; Finucane, C; Foster, J; Mather, SJ; Torres Martin de Rosales, R	1
Baziotis, N; Limouris, GS; Zafeirakis, A; Zissimopoulos, A	1
Flux, GD; Hindorf, C; Ibisch, C; Kraeber Bodéré, F	1
Dash, A; Knapp, FF; Pillai, MR	1
O'Sullivan, JM; Parker, CC; Vengalil, S	1
Ogawa, K	1
Douard, MC; George, B; Rain, JD	1
Blijham, GH; de Klerk, JM; Derksen, BH; Han, SH; Kruitwagen, CL; Tan, S; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
McCready, VR; O'Sullivan, JM	1
Silberstein, EB; Taylor, AT	1
Buffa, FM; Chittenden, SJ; Dearnaley, DP; Flux, GD; Guy, MJ; McCready, VR; O'Sullivan, JM	1
Franke, WG; Hliscs, R; Knapp, FF; Kropp, J; Liepe, K; Runge, R	1
Albers, P; Biersack, HJ; Ezziddin, S; Fimmers, R; Guhlke, S; Joe, A; Knapp, FF; Manka-Waluch, A; Palmedo, H; Reinhardt, M; Roedel, R; Schmidt-Wolf, IG	1
Kotzerke, J; Kropp, J; Liepe, K; Runge, R	1
Fuster, D; Pons, F; Vidal-Sicart, S	1
Bandurski, T; Derejko, M; Romanowicz, G; Scheffler, J	1
Endo, K; Li, S; Liu, J; Tanada, S; Tian, M; Zhang, H	1
de Klerk, JM; Lam, MG; van Rijk, PP	1
El-Mabhouh, A; Mercer, JR	1
Finlay, IG; Mason, MD; Shelley, M	1
Chen, SX; DU, JQ; Jiang, NY; Liang, JG; Liu, XG; Lu, XP	1
Bauman, G; Charette, M; Reid, R; Sathya, J	1
de Klerk, JM; Lambert, B	1
Buffa, FM; Coffey, J; Cook, G; Dearnaley, DP; Flux, G; Horwich, A; Huddart, RA; Johnson, B; McCready, VR; Norman, AR; O'Sullivan, JM; Parker, CC; Treleaven, J	1
Asano, D; Hashimoto, K; Kawashima, H; Kinuya, S; Mori, H; Mukai, T; Ogawa, K; Saji, H; Shiba, K	1
Bloch, G; Chittenden, S; Dearnaley, DP; Divoli, A; Flux, GD; Malaroda, A; O'Sullivan, JM	1
Franklin, S; Hillegonds, DJ; Shelton, DK; Vijayakumar, S; Vijayakumar, V	1
El-Mabhouh, AA; Mercer, JR	1
Koutsikos, J; Leondi, A	1
Deutsch, EA; Ketring, AR; Weininger, J	1
Blijham, GH; de Klerk, JM; Han, SH; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
McEwan, AJ	2
Lewington, VJ	2
Cosmatos, D; Eisbruch, A; Garcia, DM; Perez, CA; Poulter, CA	1
Holmes, RA	1
Ben-Josef, E; Davis, L; Porter, AT	1
Hinnefeld, JD; Hyams, DM; Maxon, HR; Moulton, JS; Samaratunga, RC; Sperling, MI; Thomas, SR; Von Kuster, LC	1
Blijham, GH; de Klerk, JM; Han, SH; Stokkel, MP; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Clarke, SE	1
Blijham, GH; de Klerk, JM; Hoekstra, A; Rutgers, DH; van Dieren, EB; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Blijham, GH; de Klerk, JM; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Silberstein, EB	1
Bender, H; Biersack, HJ; Dierke-Dzierzon, C; Grünwald, F; Mallmann, P; Palmedo, H; Reichmann, K; Schomburg, A; Schöneich, G; Zamorra, P	1
Blijham, GH; de Klerk, JM; Krouwer, HG; van Die, J; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Blijham, GH; de Klerk, JM; Han, SH; Quirijnen, JM; ten Kroode, HF; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Atkins, HL; Srivastava, SC	1
Hsieh, BT; Knapp, FF; Lin, CP; Lin, WY; Stabin, MG; Ting, G; Tsai, ZT; Wang, SJ; Yeh, SJ; Yen, TC	1
Botha, JM; Doman, MJ; Goedhals, L; Lötter, MG; Marais, J; Naudé, H; Otto, AC; Roodt, A; van Aswegen, A	1
Biersack, HJ; Dierke-Dzierzon, C; Müller, SC; Palmedo, H; Schoeneich, G	1
Holle, LH; Humke, U; Kirsch, CM; Oberhausen, E; Trampert, L; Ziegler, M	1
Biersack, HJ; Dierke-Dzierzon, C; Hauswirth, AE; Krebs, D; Palmedo, H	1
Blower, PJ; Coakley, AJ; Kettle, AG; Knapp, FF; Lam, AS; O'Doherty, MJ	1
Lerch, H	1
Biersack, HJ; Grünwald, F; Köhler, S; Krebs, D; Palmedo, H; Wagner, U	1
Blijham, GH; de Klerk, JM; Han, SH; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonneberg, BA	1
Curley, T; Daghighian, F; Goldsmith, SJ; Graham, MC; Larson, SM; Liu, GB; Scher, HI; Yeh, SD	1
Bender, H; Biersack, HJ; Carl, UM; Dierke-Dzierzon, C; Krebs, D; Palmedo, H; Risse, J	1
Brans, B; De Winter, F; Dierckx, RA; Van De Wiele, C	1
Bomanji, JB; Briggs, TW; Cassoni, AM; Sawyer, EJ; Waddington, W	1
Hsieh, BT; Hsieh, JF; Lin, WY; Ting, G; Tsai, SC; Wang, SJ	1
Bender, H; Biersack, HJ; Grünwald, F; Guhlke, S; Knapp, FF; Palmedo, H; Risse, J; Sartor, J; Schoeneich, G	1
Spencer, RP	1
Csernay, L; Láng, J; Pajor, L; Pávics, L; Róka, R; Séra, T; Thurzó, L	1
Bohuslavizki, KH; Klutmann, S	1
Franke, WG; Grüning, T; Hliscs, R; Knapp, FF; Koch, R; Kropp, J; Liepe, K; Runge, R	1
Abrahamsson, PA; Ahlgren, G; Darte, L; Flodgren, P; Garkavij, M; Strand, SE; Tennvall, J	1
Blower, PJ; Coakley, AJ; Kettle, AG; Knapp, FF; O'Doherty, MJ	1
Aras, G; Baltaci, S; Bedük, Y; Canakci, N; Ibiş, E; Küçük, NO; Ozalp, G; Soylu, A	1
Carpentier, P; Caty, A; Depreux, P; Kolesnikov-Gauthier, H; Sulman, C; Vennin, P	1
Franke, WG; Hliscs, R; Koch, R; Kropp, J; Liepe, K; Runge, R	1
Qingnuan, L; Rong, S; Wenxin, L; Xiaodong, Z	1
Franke, WG; Hliscs, R; Kropp, J; Liepe, K	1
Arteaga de Murphy, C; Croft, BY; Ferro-Flores, G; Meléndez-Alafort, L; Padilla, J; Pedraza-López, M; Ramírez, FM	1
Brenner, W; Henze, E; Kampen, AM; Kampen, WU	1
Bruland, OS; Kvinnsland, Y; Skretting, A	1
Bergomi, S; Festa, A; Maini, CL; Pasqualoni, R; Rea, S; Sciuto, R; Semprebene, A	1
Bestagno, M; Colamussi, P; Dafermou, A; Giganti, M; Piffanelli, A; Pizzocaro, C	1
De Klerk, JM; Han, SH; Tan, S; Van Rijk, PP; Zonnenberg, BA	1
Bestagno, M; Cittanti, C; Colamussi, P; Dafermou, A; Giganti, M; Piffanelli, A	1
Banerjee, S; Chaudhari, PR; Kothari, K; Pillai, MR; Samuel, G; Sarma, HD; Unni, PR; Unnikrishnan, TP	1
Li, S; Liu, J; Tian, M; Wang, J; Zhang, H; Zheng, X	1
Al-Deen, A; Buffa, FM; Chittenden, S; Cook, G; Dearnaley, DP; Flux, G; Gadd, J; Guy, M; Horwich, A; Huddart, RA; McCready, VR; Norman, AR; O'Sullivan, JM; Pomeroy, K; Treleaven, J	1
Berger, M; Chevalier, P; Galy, G; Mathieu, L	1
Curley, T; Larson, S; O'Moore, PV; Scher, HI; Tong, W; Yeh, S	1
de Klerk, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Deutsch, EA; Hertzberg, VS; Libson, KF; Maxon, HR; Moulton, JS; Samaratunga, RC; Scher, HI; Schroder, LE; Thomas, SR; Williams, CC	1
Ehrhardt, GJ; Englaro, EE; Hertzberg, VS; Maxon, HR; Moulton, JS; Samaratunga, R; Schroder, LE; Smith, H; Thomas, SR; Williams, CC	1
Ketring, AR	1
Ali, S; Deutsch, EA; Libson, K; Lukes, SJ; Maxon, HR; Thomas, SR; Williams, CC	1

Reviews

24 review(s) available for rhenium and Bone Cancer

Article	Year
Dosimetry of Bone Seeking Beta Emitters for Bone Pain Palliation Metastases. Seminars in nuclear medicine, 2022, Volume: 52, Issue:2 Topics: Bone and Bones; Bone Neoplasms; Humans; Lutetium; Pain; Radiopharmaceuticals; Rhenium; Tissue Distribution; Zoledronic Acid	2022
Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium. Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:1 Topics: Bone Neoplasms; Combined Modality Therapy; Humans; Neoplasm Metastasis; Radioisotopes; Radiopharmaceuticals; Radium; Rhenium	2014
Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals. Advanced drug delivery reviews, 2008, Volume: 60, Issue:12 Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Microspheres; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium	2008
Clinical dosimetry in the treatment of bone tumors: old and new agents. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:2 Topics: Bone Neoplasms; Humans; Pain; Palliative Care; Phosphorus Radioisotopes; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radium; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes	2011
Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications. Current radiopharmaceuticals, 2012, Volume: 5, Issue:3 Topics: Adsorption; Antibodies, Monoclonal; Arthritis, Rheumatoid; Bone Neoplasms; Carcinoma, Hepatocellular; Chromatography; Coronary Disease; Drug Combinations; Equipment Design; Humans; Iodized Oil; Liver Neoplasms; Musculoskeletal Pain; Neoplasms; Organometallic Compounds; Palliative Care; Peptides; Radioimmunotherapy; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals; Rhenium; Skin Neoplasms; Succimer	2012
Use of radionuclides in metastatic prostate cancer: pain relief and beyond. Current opinion in supportive and palliative care, 2012, Volume: 6, Issue:3 Topics: Bone Neoplasms; Humans; Male; Men's Health; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radium; Rhenium; Samarium; Strontium	2012
[Development of radiopharmaceuticals for diagnosis and therapy of metastatic bone cancer]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:10 Topics: Animals; Bone Neoplasms; Diphosphonates; Drug Design; Organometallic Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rhenium; Technetium	2012
[Metabolic radiotherapy: what role will it have in 2001?]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2002, Volume: 6, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analgesics, Opioid; Bone Neoplasms; Clinical Trials as Topic; Double-Blind Method; Forecasting; France; Hematologic Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Phosphorus Radioisotopes; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium; Strontium Radioisotopes; Treatment Outcome	2002
[Palliative treatment of metastasic bone pain]. Revista espanola de medicina nuclear, 2003, Volume: 22, Issue:6 Topics: Analgesia; Bone Neoplasms; Contraindications; Drug Costs; Forecasting; Humans; Pain; Palliative Care; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes; Treatment Outcome	2003
Application of rhenium-188 HEDP in bone metastases therapy. Nuclear medicine review. Central & Eastern Europe, 2003, Volume: 6, Issue:1 Topics: Bone Neoplasms; Etidronic Acid; Humans; Leukopenia; Organometallic Compounds; Pain; Palliative Care; Practice Patterns, Physicians'; Radiopharmaceuticals; Rhenium; Thrombocytopenia; Treatment Outcome	2003
186Re-HEDP for metastatic bone pain in breast cancer patients. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31 Suppl 1 Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Maximum Tolerated Dose; Organometallic Compounds; Pain; Palliative Care; Radiation Injuries; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Treatment Outcome	2004
Radioisotopes for the palliation of metastatic bone cancer: a systematic review. The Lancet. Oncology, 2005, Volume: 6, Issue:6 Topics: Bone Neoplasms; Humans; Neoplasm Metastasis; Pain, Intractable; Palliative Care; Radiography; Radioisotopes; Radiotherapy Dosage; Rhenium; Samarium; Strontium Radioisotopes	2005
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2005, Volume: 75, Issue:3 Topics: Bone Neoplasms; Humans; Palliative Care; Patient Selection; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Rhenium; Strontium Radioisotopes	2005
Clinical applications of 188Re-labelled radiopharmaceuticals for radionuclide therapy. Nuclear medicine communications, 2006, Volume: 27, Issue:3 Topics: Arthritis, Rheumatoid; Bone Neoplasms; Graft Occlusion, Vascular; Hematologic Neoplasms; Humans; Pain; Palliative Care; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radioisotopes; Radiopharmaceuticals; Rhenium; Treatment Outcome	2006
The management of painful bone metastases with an emphasis on radionuclide therapy. Journal of the National Medical Association, 2007, Volume: 99, Issue:7 Topics: Bone Neoplasms; Combined Modality Therapy; Humans; Neoplasm Metastasis; Pain; Palliative Care; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes	2007
Targeted radionuclide therapy for bone metastases. European journal of nuclear medicine, 1993, Volume: 20, Issue:1 Topics: Analgesics; Bone Neoplasms; Combined Modality Therapy; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Radiotherapy; Rhenium; Samarium; Strontium Radioisotopes	1993
Radiopharmaceuticals in clinical trials. Seminars in oncology, 1993, Volume: 20, Issue:3 Suppl 2 Topics: Animals; Bone Neoplasms; Clinical Trials as Topic; Humans; Palliative Care; Phosphorus Radioisotopes; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes	1993
Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rhenium. Current opinion in oncology, 1994, Volume: 6, Issue:6 Topics: Bone Neoplasms; Humans; Phosphorus Radioisotopes; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes	1994
Radionuclide therapy in oncology. Cancer treatment reviews, 1994, Volume: 20, Issue:1 Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Bone Neoplasms; Brachytherapy; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasms; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy Dosage; Rhenium; Samarium; Strontium Radioisotopes; Thyroid Neoplasms	1994
Cancer therapy using bone-seeking isotopes. Physics in medicine and biology, 1996, Volume: 41, Issue:10 Topics: Bone Neoplasms; Humans; Neoplasms; Palliative Care; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy Dosage; Rhenium; Samarium; Strontium; Tin Radioisotopes	1996
Radiolabeled bone-seeking radiopharmaceuticals. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1996, Volume: 40, Issue:3 Topics: Animals; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Tin	1996
Unsealed source therapy of painful bone metastases: an update. Seminars in nuclear medicine, 1997, Volume: 27, Issue:2 Topics: Bone Neoplasms; Clinical Trials as Topic; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Management; Palliative Care; Pentetic Acid; Phosphorus Radioisotopes; Radioisotopes; Rhenium; Safety; Strontium Radioisotopes; Syndrome	1997
186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2001, Volume: 45, Issue:1 Topics: Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain, Intractable; Palliative Care; Radiopharmaceuticals; Rhenium; Tin Radioisotopes	2001
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors. Advances in experimental medicine and biology, 1992, Volume: 324 Topics: Animals; Bone Neoplasms; Dogs; Drug Screening Assays, Antitumor; Etidronic Acid; Growth Substances; Humans; Male; Neoplasm Proteins; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Suramin	1992

Trials

28 trial(s) available for rhenium and Bone Cancer

Article	Year
Pain palliative therapy in women with breast cancer osseous metastatic disease and the role of specific serum cytokines as prognostic factors. Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:3 Topics: Aged; Bone Neoplasms; Breast Neoplasms; Cytokines; Female; Humans; Interleukin-6; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Rhenium; Strontium Radioisotopes	2014
(188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:9 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Capecitabine; Deoxycytidine; Drug Resistance, Neoplasm; Etidronic Acid; Fluorouracil; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radioisotopes; Radiopharmaceuticals; Rhenium	2009
The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:9 Topics: Aged; Bone Neoplasms; Double-Blind Method; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rhenium; Tin Radioisotopes	2002
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:8 Topics: Body Burden; Bone Marrow; Bone Neoplasms; Computer Simulation; Etidronic Acid; Humans; Injections, Intravenous; Male; Models, Biological; Organometallic Compounds; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness; Rhenium; Statistics as Topic; Treatment Outcome; Whole-Body Counting	2003
Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:6 Topics: Aged; Aged, 80 and over; Body Burden; Bone Marrow; Bone Neoplasms; Etidronic Acid; Half-Life; Humans; Injections, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Organometallic Compounds; Prostatic Neoplasms; Radiation Dosage; Radiometry; Rhenium; Tissue Distribution; Urinary Bladder; Whole-Body Counting	2003
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Aug-01, Volume: 21, Issue:15 Topics: Aged; Bone Neoplasms; Disease Progression; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain Measurement; Pain, Intractable; Palliative Care; Prospective Studies; Prostatic Neoplasms; Radiotherapy Dosage; Rhenium; Treatment Outcome	2003
Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases. British journal of cancer, 2003, Aug-18, Volume: 89, Issue:4 Topics: Aged; Aged, 80 and over; Blood Cell Count; Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	2003
[Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Pain; Pain Management; Pamidronate; Radioisotopes; Rhenium	2005
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:9 Topics: Aged; Bone Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Peripheral Blood Stem Cell Transplantation; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Transplantation, Autologous	2006
Tumor dosimetry on SPECT (186)Re-HEDP scans: variations in the results from the reconstruction methods used. Cancer biotherapy & radiopharmaceuticals, 2007, Volume: 22, Issue:1 Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Prostatic Neoplasms; Radioisotopes; Rhenium; Tomography, Emission-Computed, Single-Photon	2007
Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer. European journal of nuclear medicine, 1994, Volume: 21, Issue:10 Topics: Aged; Bone Neoplasms; Etidronic Acid; Humans; Male; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium; Thrombocytopenia	1994
Irradiation in relapsing carcinoma of the prostate. Cancer, 1993, Feb-01, Volume: 71, Issue:3 Suppl Topics: Bone Neoplasms; Brachytherapy; Brain Neoplasms; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Phosphorus Radioisotopes; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium; Spinal Cord Compression; Strontium Radioisotopes	1993
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:2 Topics: Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Palliative Care; Radioisotopes; Rhenium; Thrombocytopenia	1996
Dosage and response in radiopharmaceutical therapy of painful osseous metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Male; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Thrombocytopenia	1996
[Pain therapy with rhenium-186 HEDP in multiple bone metastases]. Nuklearmedizin. Nuclear medicine, 1996, Volume: 35, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Etidronic Acid; Female; Humans; Male; Neoplasm Metastasis; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors; Tomography, Emission-Computed	1996
Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:9 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium; Time Factors	1996
Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results. Scandinavian journal of urology and nephrology, 1997, Volume: 31, Issue:5 Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors	1997
186Re-etidronate in breast cancer patients with metastatic bone pain. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:4 Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Organometallic Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Rhenium	1999
Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:6 Topics: Androgens; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Kidney; Male; Metabolic Clearance Rate; Organometallic Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Whole-Body Counting	1999
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. European journal of nuclear medicine, 2000, Volume: 27, Issue:2 Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Pain Measurement; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium	2000
[Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain]. Orvosi hetilap, 2000, May-07, Volume: 141, Issue:19 Topics: Alkaline Phosphatase; Analgesics; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	2000
Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:10 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Time Factors	2000
[Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases]. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:6 Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Strontium Radioisotopes; Tomography, X-Ray Computed	2000
Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients. Breast cancer research and treatment, 2001, Volume: 66, Issue:2 Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Etidronic Acid; Female; Humans; Infusions, Intravenous; Karnofsky Performance Status; Middle Aged; Organometallic Compounds; Pain Measurement; Pain, Intractable; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Strontium Radioisotopes; Treatment Outcome	2001
Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2001, Volume: 45, Issue:1 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rhenium; Strontium; Strontium Radioisotopes; Tin Radioisotopes	2001
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. British journal of cancer, 2002, Jun-05, Volume: 86, Issue:11 Topics: Bone and Bones; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Etidronic Acid; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Organometallic Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiotherapy; Recombinant Proteins; Rhenium	2002
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors. Advances in experimental medicine and biology, 1992, Volume: 324 Topics: Animals; Bone Neoplasms; Dogs; Drug Screening Assays, Antitumor; Etidronic Acid; Growth Substances; Humans; Male; Neoplasm Proteins; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Suramin	1992
Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:10 Topics: Aged; Bone Neoplasms; Double-Blind Method; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Technetium Tc 99m Medronate	1991

Other Studies

51 other study(ies) available for rhenium and Bone Cancer

Article	Year
ESTIMATION OF HUMAN DOSE OF 188/186RE-HEDP COCKTAIL BASED ON OLINDA/EXM AND DISTRIBUTION DATA IN RATS. Radiation protection dosimetry, 2020, Aug-28, Volume: 190, Issue:2 Topics: Bone Neoplasms; Etidronic Acid; Humans; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution	2020
Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods. Medical physics, 2014, Volume: 41, Issue:11 Topics: Algorithms; Beta Particles; Bone Neoplasms; Computer Simulation; DNA; DNA Damage; DNA Repair; Humans; Lutetium; Monte Carlo Method; Neoplasm Metastasis; Palliative Care; Radioisotopes; Radiopharmaceuticals; Radium; Rhenium; Samarium; Strontium Radioisotopes	2014
Novel (188)Re multi-functional bone-seeking compounds: Synthesis, biological and radiotoxic effects in metastatic breast cancer cells. Nuclear medicine and biology, 2016, Volume: 43, Issue:2 Topics: Animals; Biological Transport; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Chemistry Techniques, Synthetic; Durapatite; Female; Mice; Neoplasm Metastasis; Organometallic Compounds; Radioisotopes; Rhenium; Tissue Distribution	2016
Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP. Nuklearmedizin. Nuclear medicine, 2009, Volume: 48, Issue:1 Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Rhenium; Safety; Samarium; Strontium; Strontium Radioisotopes	2009
Autoradiographic studies of rhenium-188-hydroxyethylidine diphosphonate in normal skeleton and osteoblastic bone metastases in a rat model of metastatic prostate cancer. Nuclear medicine communications, 2009, Volume: 30, Issue:9 Topics: Animals; Autoradiography; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Etidronic Acid; Lumbar Vertebrae; Male; Osteoblasts; Prostatic Neoplasms; Radioisotopes; Rats; Rhenium; Tissue Distribution	2009
Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases. Chemical communications (Cambridge, England), 2009, Aug-28, Issue:32 Topics: Animals; Bone Neoplasms; Diphosphonates; Female; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Molecular Structure; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rhenium	2009
188Re(CO)3-dipicolylamine-alendronate: a new bisphosphonate conjugate for the radiotherapy of bone metastases. Bioconjugate chemistry, 2010, May-19, Volume: 21, Issue:5 Topics: Alendronate; Animals; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Mice; Mice, Inbred BALB C; Radioisotopes; Radiopharmaceuticals; Rhenium	2010
Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Predictive Value of Tests; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium	2011
New approaches to the use of unsealed source radionuclide therapy for skeletal metastases. Kaku igaku. The Japanese journal of nuclear medicine, 2002, Volume: 39, Issue:3 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radioisotopes; Rhenium	2002
EANM procedure guidelines for treatment of refractory metastatic bone pain. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:3 Topics: Bone Neoplasms; Etidronic Acid; Europe; Humans; Nuclear Medicine; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Patient Selection; Radiopharmaceuticals; Radiotherapy; Rhenium; Societies, Medical; Treatment Outcome	2003
Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:5 Topics: Adult; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Radionuclide Imaging; Rhenium	2003
188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2005, Volume: 62, Issue:4 Topics: Animals; Bone Neoplasms; Diphosphonates; Female; Fluorouracil; Isotope Labeling; Mice; Mice, Inbred BALB C; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution	2005
Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:1 Topics: Animals; Bone and Bones; Bone Neoplasms; Diphosphonates; Disease Models, Animal; Female; Mammary Neoplasms, Animal; Mice; Neoplasm Metastasis; Organometallic Compounds; Pain; Radioisotopes; Rats; Rats, Sprague-Dawley; Rhenium; Time Factors	2007
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:7 Topics: Animals; Bone and Bones; Bone Neoplasms; Cattle; Combined Modality Therapy; Deoxycytidine; Diphosphonates; Durapatite; Etidronic Acid; Female; Gemcitabine; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution	2008
Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:7 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium	2008
186Re-HEDP: a potential therapeutic bone agent. Nuklearmedizin. Nuclear medicine, 1984, Volume: 23, Issue:2 Topics: Animals; Bone and Bones; Bone Neoplasms; Dogs; Etidronic Acid; Mice; Radioisotopes; Radionuclide Imaging; Rats; Rhenium	1984
Pain palliation and nuclear medicine. European journal of nuclear medicine, 1993, Volume: 20, Issue:1 Topics: Bone Neoplasms; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes	1993
A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDP. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:2 Topics: Algorithms; Autoradiography; Bone Neoplasms; Etidronic Acid; Humans; Monte Carlo Method; Organometallic Compounds; Radiation Dosage; Radioisotopes; Rhenium; Tin	1995
Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:9 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Middle Aged; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Thrombocytopenia	1994
Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:1 Topics: Aged; Bone Marrow; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Palliative Care; Platelet Count; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Rhenium; Thrombocytopenia	1996
Transient cranial neuropathy in prostatic cancer with bone metastases after rhenium-186-HEDP treatment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:3 Topics: Bone Neoplasms; Cranial Nerve Diseases; Etidronic Acid; Glossopharyngeal Nerve; Humans; Hypoglossal Nerve; Male; Mandibular Nerve; Middle Aged; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors	1996
Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases. European journal of nuclear medicine, 1997, Volume: 24, Issue:6 Topics: Animals; Bone Neoplasms; Etidronic Acid; Half-Life; Humans; Male; Rabbits; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rhenium; Tissue Distribution	1997
Radiation dose estimates of 186Re-hydroxyethylidene diphosphonate for palliation of metastatic osseous lesions: an animal model study. Nuclear medicine communications, 1997, Volume: 18, Issue:6 Topics: Adult; Animals; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Organometallic Compounds; Palliative Care; Papio; Prostatic Neoplasms; Radiopharmaceuticals; Rhenium; Tissue Distribution; Urinary Bladder	1997
[Palliative treatment for pain in osseous metastasized prostatic carcinoma with osteotropic rhenium-186 hydroxyethylidene diphosphonate (HEDP)]. Der Urologe. Ausg. A, 1997, Volume: 36, Issue:6 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diphosphonates; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Rhenium	1997
[Pain therapy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP]. Zentralblatt fur Gynakologie, 1998, Volume: 120, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Middle Aged; Pain Measurement; Palliative Care; Quality of Life; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	1998
Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies. European journal of nuclear medicine, 1998, Volume: 25, Issue:6 Topics: Aged; Aged, 80 and over; Animals; Bone Neoplasms; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Middle Aged; Organometallic Compounds; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Succimer; Tissue Distribution	1998
[Advanced prostate carcinoma: systemic radionuclide therapy of bone metastasis with rhenium-168-hydroxyethylidine diphosphonate]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1998, Volume: 174, Issue:7 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Treatment Outcome	1998
Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP. Clinical nuclear medicine, 1998, Volume: 23, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Etidronic Acid; Female; Humans; Middle Aged; Palliative Care; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate	1998
Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases. Clinical nuclear medicine, 1999, Volume: 24, Issue:9 Topics: Adult; Aged; Analgesics; Blood Cell Count; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Injections, Intravenous; Middle Aged; Pain; Pain Measurement; Palliative Care; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	1999
Visualization of the stomach on rhenium-186 HEDP imaging after therapy for metastasized prostate carcinoma. Clinical nuclear medicine, 1999, Volume: 24, Issue:11 Topics: Aged; Bone Neoplasms; Etidronic Acid; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Stomach	1999
Rhenium-186 HEDP as a boost to external beam irradiation in osteosarcoma. The British journal of radiology, 1999, Volume: 72, Issue:864 Topics: Adult; Bone Neoplasms; Dose-Response Relationship, Radiation; Humans; Male; Osteosarcoma; Radioisotopes; Radionuclide Imaging; Rhenium	1999
Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases. Nuclear medicine and biology, 1999, Volume: 26, Issue:8 Topics: Animals; Bone and Bones; Bone Neoplasms; Diphosphonates; Etidronic Acid; Injections, Intravenous; Isotope Labeling; Neoplasm Metastasis; Organometallic Compounds; Rabbits; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Soft Tissue Neoplasms; Tissue Distribution; Whole-Body Counting	1999
Quantifying leukocyte and thrombocyte suppression-recovery after Re-186 HEDP for bone metastases. Clinical nuclear medicine, 2000, Volume: 25, Issue:6 Topics: Blood Platelets; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Carcinoma; Etidronic Acid; Female; Follow-Up Studies; Forecasting; Humans; Leukocyte Count; Leukocytes; Leukopenia; Organometallic Compounds; Platelet Count; Radiopharmaceuticals; Rhenium; Thrombocytopenia; Tin Radioisotopes	2000
[Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP]. MMW Fortschritte der Medizin, 1999, Nov-04, Volume: 141, Issue:44 Topics: Aged; Bone Neoplasms; Etidronic Acid; Humans; Male; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Treatment Outcome	1999
Rhenium-188-HEDP in the palliative treatment of bone metastases. Cancer biotherapy & radiopharmaceuticals, 2000, Volume: 15, Issue:3 Topics: Aged; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Palliative Care; Radioisotopes; Rhenium	2000
Palliative radiation with a radiolabeled diphosphonate (rhenium-186 etidronate) in patients with hormone-refractory disseminated prostate carcinoma. Scandinavian journal of urology and nephrology, 2000, Volume: 34, Issue:3 Topics: Bone Neoplasms; Humans; Male; Pain Management; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Survival Analysis; Technetium Tc 99m Medronate; Treatment Outcome	2000
99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. European journal of nuclear medicine, 2000, Volume: 27, Issue:9 Topics: Aged; Bone Neoplasms; Humans; Male; Middle Aged; Phantoms, Imaging; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid	2000
Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases. Annals of nuclear medicine, 2000, Volume: 14, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Rhenium	2000
Preparation of (188Re) Re-AEDP and its biodistribution studies. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2000, Volume: 53, Issue:6 Topics: Animals; Bone Neoplasms; Diphosphonates; Drug Carriers; Drug Stability; Female; Hydrogen-Ion Concentration; Palliative Care; Radiopharmaceuticals; Rats; Rhenium; Tin Compounds; Tissue Distribution	2000
Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy. Clinical nuclear medicine, 2000, Volume: 25, Issue:11 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate	2000
Labelling of Re-ABP with 188Re for bone pain palliation. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2001, Volume: 54, Issue:3 Topics: Alendronate; Animals; Bone Neoplasms; Humans; Indicators and Reagents; Palliative Care; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Rhenium; Tissue Distribution	2001
Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:2 Topics: Aged; Bone and Bones; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Muscle, Skeletal; Organometallic Compounds; Organophosphorus Compounds; Pain Management; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Samarium; Thigh; Urinary Bladder	2001
Radionuclide therapy with bone-seeking compounds: Monte Carlo calculations of dose-volume histograms for bone marrow in trabecular bone. Physics in medicine and biology, 2001, Volume: 46, Issue:4 Topics: Age Factors; Bone Neoplasms; Cell Survival; Dose-Response Relationship, Radiation; Hematopoietic Stem Cells; Humans; Isotopes; Models, Theoretical; Monte Carlo Method; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Rhenium; Samarium; Strontium Radioisotopes; Tin	2001
A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. European journal of nuclear medicine, 2001, Volume: 28, Issue:7 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Etidronic Acid; Humans; Injections, Intravenous; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Strontium; Strontium Radioisotopes	2001
186Re-1,4,8,11-tetraaza cyclotetradecyl-1,4,8,11-tetramethylene phosphonic acid: a novel agent for possible use in metastatic bone-pain palliation. Nuclear medicine and biology, 2001, Volume: 28, Issue:6 Topics: Analgesics; Animals; Bone Neoplasms; Etidronic Acid; Heterocyclic Compounds, 1-Ring; Injections, Intravenous; Male; Organometallic Compounds; Organophosphonates; Pain; Rabbits; Rats; Rats, Sprague-Dawley; Rhenium; Tissue Distribution	2001
Rhenium-188 HEDP to treat painful bone metastases. Clinical nuclear medicine, 2001, Volume: 26, Issue:11 Topics: Bone Neoplasms; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Palliative Care; Platelet Count; Radionuclide Imaging; Radiopharmaceuticals; Rhenium	2001
Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms. The International journal of applied radiation and isotopes, 1979, Volume: 30, Issue:12 Topics: Animals; Bone Neoplasms; Etidronic Acid; Isotope Labeling; Radioisotopes; Radionuclide Imaging; Rats; Rhenium; Technology, Pharmaceutical; Tissue Distribution	1979
Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:5 Topics: Aged; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Half-Life; Humans; Male; Middle Aged; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium	1992
Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer. Radiology, 1990, Volume: 176, Issue:1 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Estrogens; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiotherapy Dosage; Rhenium; Tin	1990
153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1987, Volume: 14, Issue:3 Topics: Animals; Bone Neoplasms; Dogs; Etidronic Acid; Humans; Kinetics; Organophosphorus Compounds; Pain; Rabbits; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Technetium Tc 99m Medronate; Tissue Distribution	1987
Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies. Radiology, 1988, Volume: 166, Issue:2 Topics: Adult; Aged; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Radioisotopes; Radiotherapy Dosage; Rhenium; Tissue Distribution	1988